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Copyright © 200? JCBN Summary Recently, it has been reported that α-tocopherol (α-Toc) is effective for amelioration
of liver damage. However, it is unknown whether other vitamin E analogs are effective. In this
study, we investigated the effects of γ-tocopherol (γ-Toc) and tocotrienols (T3) in rats with fatty
liver. Rats fed a vitamin E-deficient diet for four weeks were divided into eight groups:
Control, carbon tetrachloride (CCl4),  α-Toc,  α-Toc + CCl4,  γ-Toc, γ-Toc + CCl4, T3 mix, T3
mix + CCl4. After a 24 h fast, the rats were administered 20 mg of each of the vitamin E
analogs, respectively. Moreover, the CCl4 group were given 0.5 ml/kg body weight corn oil
preparation containing CCl4 6 h after vitamin E administration. We measured the activities of
aspartate aminotransferase and alanine aminotransferase (ALT) in plasma, and the contents
of triglyceride (TG), total cholesterol (T-Chol) and vitamin E analogs in the liver. Also, we
determined the hepatic expression of mRNA for inflammatory cytokines. The liver TG content
in the γ-Toc + CCl4 and T3 mix + CCl4 groups was decreased in comparison with the CCl4
group. Moreover, ALT activity in the T3 mix + CCl4 group was significantly lower than CCl4
group. These findings suggest that γ-Toc and T3 are effective for amelioration of fatty liver.
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Introduction
Carbon tetrachloride (CCl4) is a chemical agent widely
used for experimental induction of fatty liver and liver
fibrosis in animals [1]. It is considered that CCl4 is metabo-
lized by cytochrome P-450 (CYP) to unstable trichloro-
methyl free radicals (e.g. CCl3, CCl3O2), which then bind
covalently to membrane proteins, finally causing lipid per-
oxidation [1–4]. The activities of aspartate aminotransferase
(AST) and alanine aminotransferase (ALT) in rat plasma rise
remarkably with hepatocyte necrosis and lipid accumulation
when CCl4 is administered to rats. Therefore, this model is
used widely to induce various fatty liver states.
Vitamin E is present naturally in the form of eight
analogs, each differing in the number and position of the
methyl groups on the chroman ring and by the presence or
absence of a double bond on the phytyl side chain. One
group, the tocopherols (Tocs), have a saturated phytyl side
chain, and the other, the tocotrienols (T3s), have an un-
saturated phytyl side chain. Each of the groups can occur in
α-, β-, γ-, or δ-forms. Especially, α- and γ-Toc are abundant
in vegetable oil and seeds such as almonds and peanuts, and
act as lipid-soluble antioxidants in cell membranes, being
important for maintenance of cell membrane fluidity. When
administered orally, Toc analogs (especially α- and γ-Toc)
are equally absorbed from the small intestine without dis-
crimination. After uptake into intestinal cells, Toc analogs
are integrated into chylomicrons. Chylomicron remnants are
catabolized during circulation by lipoprotein lipase. After
uptake of chylomicron remnants by the liver, Toc analogs
are discriminated by α-Toc transfer protein (α-TTP) in theProtective Effects of Vitamin E Analogs on Rat Fatty Liver
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liver, which transports α-Toc preferentially over γ-Toc into
very-low-density lipoprotein (VLDL) during assembly [5].
Therefore, non α-Toc (γ-Toc, T3) remains in the liver.
Accordingly, we hypothesized that non α-Toc may show
function more effectively than α-Toc in the liver. Some
investigators have reported the effect of α-Toc on liver
injury induced by CCl4. It has already been reported that
administration of α-Toc or an α-Toc-enriched diet sup-
presses the rise of plasma ALT activity and concentration
of bilirubin induced by CCl4 [ 6,  7], whereas non α-Toc
does not. In the present study we investigated the preventive
effects of γ-Toc and T3 mix against lipid peroxidation, and
also AST activities in CCl4-treated rats.
Experimental Procedures
Animals and diets
Male SD-IGS rats (six weeks old) were purchased from
Charles River Japan, Inc. (Kanagawa，Japan). Forty rats
were divided into eight groups: Control (C), CCl4 (CCl4),
α-Toc (αT),  α-Toc + CCl4 ( αT + CCl4),  γ-Toc (γT),  γ-
Toc + CCl4 ( γT + CCl4), T3 mix (T3), T3 mix + CCl4
(T3 + CCl4). They were housed individually in stainless
steel wire netting cages, and fed a commercial chow
(Nippon Clea Co., Tokyo, Japan) for three days. The animals
were kept in an environment controlled at 23 ± 2°C and
55 ± 5% humidity, with a 12 h/12 h light-dark cycle. Later,
the rats were switched to a vitamin E-deficient diet for four
weeks. This diet consisted of 8% vitamin E-deficient corn
oil mixed with vitamin E-deficient feed (AIN76, Funabashi
farm, Inc., Chiba, Japan). All experiments were conducted
in accordance with the guidelines for the care and use of
laboratory animals at Kanagawa Institute of Technology.
Administration of vitamin E analogs and induction of liver
damage by CCl4
After 24 h of fasting, 20 mg of each vitamin E analog was
administered to the rats. The purity of T3 mix (α-T3; 37.8%,
β-T3; 4.0%, γ-T3; 45.5%, δ-T3; 10.7%) was 98%. The
purity of α- and γ-Toc were above 96.1% respectively. All
vitamin E analogs were gifted by Eisai Food & Chemical
Co., Ltd. (Tokyo, Japan). Six hours later, a mixture of CCl4
and stripped corn oil (1:1, 1 ml/kg body weight; 0.5 ml/kg
body weight as CCl4) was administered orally to the rats.
The control rats were given stripped corn oil alone as a
placebo. After 6 h of CCl4 administration, all the rats
were killed under diethyl ether anesthesia, and arterial
blood, liver, adipose tissue, kidney, and adrenal gland
were removed for analysis.
The plasma was separated from blood cells by centrifuga-
tion at 3,000 rpm for 10 min. All tissues were immediately
stored at −80°C until analysis for biological parameters.
Liver samples to be used for RNA isolation were soaked in
RNA later solution immediately and stored at −80°C. Liver
samples to be used for histopathological examination were
fixed in 10% formalin.
Quantitative analysis of vitamin E analogs using HPLC
The quantity of vitamin E in each organ was measured
using Ueda’s method [8]. A 0.1 g sample of each organ was
homogenized with 0.9 ml of 0.9% NaCl (weight/vol)
solution. The resulting homogenate (0.1 ml) was pipetted
into a 10 ml centrifuge tube, and 50 μl of 1,2,2,5,7,8-
pentamethyl-6-hydroxychroman (PMC, 1 μg/ml) as an
internal standard and 1.0 ml of ethanolic pyrogallol (6%,
weight/vol) were added to each tube with stirring. After
0.2 ml of 60% (weight/vol) KOH solution had been added
to each tube, the contents were saponified at 70°C for
30 min. After cooling, vitamin E analogs were extracted
with 4.5 ml of 1% sodium chloride solution and 3.0 ml of
10% ethyl acetate/n-hexane solution, and centrifuged at
3,000 rpm at 4°C for 5 min. A 2.0 ml aliquot of the upper
layer was evaporated, dissolved in 0.2 ml of n-hexane, and
subjected to HPLC. The HPLC system consisted of a pump,
degasser, column oven, and detector (LC-20AD, DGU-20A3,
CTO-20A and RF-10AXL, Shimadzu Co., Kyoto, Japan).
The analytical conditions were as follows: column, Capcell
pak NH2 column (4.6 mm I.D. ×250 mm; Shiseido, Tokyo,
Japan); mobile phase, n-hexan-isopropanol (98:2); flow
rate, 1.0 ml/min; detection wavelength, 325 nm.
Measurement of liver damage markers and lipid concentra-
tion in plasma
AST and ALT activities and triglyceride (TG), total
cholesterol (T-Chol) concentrations in plasma were mea-
sured using a biochemical autoanalyzer (CA-180; Furuno
Electric Co., Ltd., Hyogo, Japan).
Measurement of liver lipid content
Total lipid in the liver was extracted by the method of
Folch [9]. A 0.9 g sample of liver was ground with sodium
sulfate and extracted with chloroform:methanol = 2:1, and
then made up to 25 ml. A 125 μl aliquot of the extract
was added to 125 μl of 1% TritonX-100 ethanol solution,
followed by hearting at 50°C overnight, and then dissolved
in 15 μl of distilled water. TG and T-Chol concentrations in
liver were measured using a biochemical autoanalyzer.
Measurement of mRNA expression of inflammatory cytokines
in liver
Total RNA was extracted from liver tissues using RNAiso.
The quantity and purity of the RNA were determined from
the absorbance at 258/280 nm. Total RNA was reverse-
transcribed into cDNA using a high-capacity RNA-to-cDNA
kit in accordance with the manufacturer’s protocol. 7500 Fast
Real-Time PCR system and real time PCR kit (TaqMan®R. Yachi et al.
J. Clin. Biochem. Nutr.
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Gene Expression Assays, Applied Biosystems Japan Ltd.,
Tokyo, Japan) were employed based on the manufacture’s
instruction.  β-actin was used as an internal control. The
content of the primer/probe mixture of inflammatory cyto-
kines and β-actin is shown in Table 1, and PCR thermal
cycling conditions are shown in Table 2.
Statistical analysis
All data are expressed as the mean ± SD. Statistical
analysis was performed by one-way ANOVA, followed by
Bonferroni post hoc test. Statistical analyses were performed
using Kaleida Graph ver. 4 for Windows (Hulinks Inc.,
Tokyo, Japan). Differences were considered to be significant
at p<0.05.
Results
Liver weight and lipid content
There were no significant differences in liver weight
among the groups. The content of TG in liver was increased
by administration of CCl4, but the increase was significantly
suppressed by administration of T3. On the other hand, there
were no significant differences in liver T-Chol content
among the groups (Fig. 1). In addition, histopathological
examination of the liver was performed after hematoxylin-
eosin staining. Lipid accumulation in the liver was confirmed
in the CCl4 group, αT + CCl4 group, γT + CCl4 group and
T3 + CCl4 group after administration of CCl4, but that in the
T3 + CCl4 group was lower than in the CCl4 group (Fig. 2).
Activities of liver damage markers and lipid concentrations
in plasma
AST activity in plasma was increased by administration
of CCl4, but this was unaffected by administration of vitamin
E analogs. On the other hand, ALT activity also tended to
increase after administration of CCl4. However, the rise in
the plasma ALT level tended to be suppressed by γ-Toc
administration, and T3 had a significant suppressive effect
(Fig. 3). There were no significant differences in the TG and
T-Chol concentrations in plasma among the groups (data not
shown).
Table 1. Primer probe mixture of inflammatory cytokines and
β-Actin
Assey ID and reference sequence number of primer probe mixtures
used in TaqMan® Gene Expression Assays (Applied Biosystems).
Assay ID Refseq
Rat TNF-α Rn99999009_m1 NM_031512.1
Rat IL1-β Rn99999011_m1 NM_012589.1
Rat IL6 Rn99999017_m1 NM_012675.2
Rat β-actin Rn00667869_m1 NM_031144.2
Table 2. Thermal cycling condition
Step 1 Step 2
Hold 40 Cycle
temperature 95°C9 5 °C6 0 °C
time 20 s 3 s 30 s
Fig. 1. Effects of vitamin E analogs on lipid contents of rat liver after administration of CCl4; (A) Liver TG content. (B) Liver T-Chol
content. Rats were fed a vitamin E-deficient diet for four weeks. After a 24 h fast, 20 mg of each vitamin E analog was
administered. Six hours later, a mixture of CCl4 and stripped corn oil (1:1, 1 ml/kg body weight; 0.5 ml/kg body weight as CCl4)
was orally administered to the rats. The control rats were given stripped corn oil alone as a placebo. Six hours after CCl4 admin-
istration, the liver was removed and its TG and T-Chol contents were measured. C; Control group, CCl4; CCl4 dosage group,
αT; α-Toc dosage group, αT + CCl4; α-Toc + CCl4 dosage group, γT; γ-Toc dosage group, γT + CCl4; γ-Toc + CCl4 dosage
group, T3; T3 mix dosage group, T3 + CCl4; T3 mix + CCl4 dosage group. The values are mean ± SD for 5 rats, *p<0.05,
***p<0.001 (one-way ANOVA followed by Bonferroni post hoc test).Protective Effects of Vitamin E Analogs on Rat Fatty Liver
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Expression of mRNA for inflammatory cytokines in liver
Expression of mRNA for tumor necrosis factor alpha
(TNF-α) and interleukin-1 (IL1)-β in the liver was increased
by administration of CCl4 (Fig. 4), suggesting that CCl4
administration caused inflammation of the liver parenchyma.
The expression of TNF-α and IL1-β mRNA was increased
further when γ-Toc was administered in such a state.
Vitamin E analog contents of various tissues
The α-Toc content of liver and plasma was not changed
Fig. 2. Histopathology of rat liver after administration of CCl4. C; Control group, CCl4; CCl4 dosage group, γT+C C l 4; γ-Toc + CCl4
dosage group, T3 + CCl4; T3 mix + CCl4 dosage group (stained with hematoxylin-eosin; original magnification ×400).
Fig. 3. Effects of vitamin E analogs on liver damage marker activity in plasma of rats administered CCl4; (A) Plasma AST activity. (B)
Plasma ALT activity. Rats were fed a vitamin E-deficient diet for four weeks. After a 24 h fast, 20 mg of each vitamin E analog
was administered to the rats. Six hours later, a mixture of CCl4 and stripped corn oil (1:1, 1 ml/kg body weight; 0.5 ml/kg body
weight as CCl4) was administered orally to the rats. The control rats were given stripped corn oil alone as a placebo. Six
hours after CCl4 administration, plasma samples were taken and the AST and ALT activities were measured. C; Control group,
CCl4; CCl4 dosage group, αT; α-Toc dosage group, αT + CCl4; α-Toc + CCl4 dosage group, γT; γ-Toc dosage group, γT + CCl4;
γ-Toc + CCl4 dosage group, T3; T3 mix dosage group, T3 + CCl4; T3 mix + CCl4 dosage group. The values are mean ± SD for
5 rats, *p<0.05, ***p<0.001 (one-way ANOVA followed by Bonferroni post hoc test).R. Yachi et al.
J. Clin. Biochem. Nutr.
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by administration of CCl4. However, the γ-Toc content of
the liver showed a tendency to decrease. On the other hand,
the α-T3 content of plasma was significantly decreased by
CCl4 (Fig. 5). There were no significant differences in the
quantity of vitamin E analogs in other tissues.
Discussion
In this study, we investigated the effects of γ-Toc and T3
on fatty liver induced by CCl4 in rats. At first, liver weight
was increased in each group by administration of CCl4,
thus confirming the induction of liver hypertrophy. As the
TG content of the liver was also increased, this hypertrophy
appeared to be caused by accumulation of TG. Because the
increase in the liver TG content was suppressed by admin-
istration of T3, the latter may regulate lipid accumulation in
the liver. Various hypotheses have been proposed to explain
the mechanism of fatty liver induced by administration of
CCl4. Recknagel et al. [10] suggested that CCl4 controls the
secession of ribosome and liver proteosynthesis, and blocks
lipoprotein secretion. In addition, the lipid accumulation is
associated with deactivation of metabolizing enzymes. In
fact, deactivation of various metabolic enzymes and a
decrease of the P450 content in liver by administration of
CCl4 have confirmed in both in vitro and in vivo systems
[11,  12]. Because lipid accumulation in the liver was
inhibited by T3 administration, T3 play a role in lipoprotein
synthesis and the transportation of lipids, and may possibly
inhibit the deactivation of metabolic enzymes.
It is known that AST and ALT activity in plasma is
increased by acute liver damage. In particular, plasma ALT
activity increases as a result of destruction and necrosis of
hepatocytes. As ALT activity was inhibited by administra-
tion of T3, hepatocyte necrosis may have been suppressed. It
has been reported that α-Toc ameliorates fatty liver damage
induced by CCl4; ALT activity and the concentration of
billirubin were lower, and liver fibrosis was inhibited in
rats fed an α-Toc-enriched diet [7]. In the present experi-
ment, ALT activity tended to be lower in the γ-Toc group,
and was significantly lower in the T3 group. Therefore, it is
suggested that T3 suppresses the necrosis of hepatocytes
by inhibition of CCl4-induced lipid peroxidation. It has
reported that α-T3 possesses 40–60 times higher antioxidant
activity against oxidative damage than α-Toc [13]. Conse-
quently, we suggested that T3, especially α-T3, restrained
strongly lipid peroxidation in the liver than α-Toc, and
controlled lipid accumulation to the liver and cell death. A
further examination is necessary for comparison of the effect
of each T3 analog.
The α-T3 content of plasma was decreased by administra-
tion of CCl4, whereas the liver α-T3 content was unaffected.
The  α-Toc is preferentially transported by α-TTP in
comparison with other vitamin E analogs, and is used for
VLDL synthesis [5]. It is suggested that γ-Toc and T3 are
accumulated in the liver and metabolized immediately. As it
has been reported that CCl4 deactivates CYP, we considered
that the metabolism of vitamin E may be interrupted by
CCl4, and that T3 may remain in the liver for a long time.
Consequently, we suggest that T3 may trap trichloro radicals
in the liver, and thus show antioxidant activity.
Kupper cells, which are fixed macrophages, are activated
by liver damage, leading to production of inflammatory
Fig. 4. Effects of vitamin E analogs on expression of inflammatory cytokine mRNAs in liver of rats administered CCl4; (A) Liver
TNF-α mRNA expression. (B) Liver IL1-β mRNA expression. Rats were fed a vitamin E-deficient diet for four weeks. After a
24 h fast, 20 mg of each vitamin E analog was administered to the rats. Six hours later, a mixture of CCl4 and stripped corn oil
(1:1, 1 ml/kg body weight; 0.5 ml/kg body weight as CCl4) was administered orally to the rats. The control rats were given
stripped corn oil alone as a placebo. Six hours after CCl4 administration, the liver was removed and its expression of TNF-α and
IL1-β mRNAs was measured by real-time PCR. C; Control group, CCl4; CCl4 dosage group, αT;  α-Toc dosage group,
αT + CCl4;  α-Toc + CCl4 dosage group, γT; γ-Toc dosage group, γT + CCl4; γ-Toc + CCl4 dosage group, T3; T3 mix dosage
group, T3 + CCl4; T3 mix + CCl4 dosage group. The values are mean ± SD for 5 rats, *p<0.05, **p<0.01, ***p<0.001 (one-way
ANOVA followed by Bonferroni post hoc test).Protective Effects of Vitamin E Analogs on Rat Fatty Liver
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cytokines such as TNF-α and IL1-β. This inflammation
spreads by stimulation of the endothelium, and leads to
localized migration of monocytes and neutrophils. IL-6 is
also produced by T cells. In the present study, we found
that the expression of mRNA for inflammatory cytokines
was drastically increased by CCl4. However, the vitamin E
analogs T3, α-Toc and γ-Toc, did not affect the expression of
inflammatory cytokine mRNAs. Because the expression
mRNAs for inflammatory proteins changes markedly in
states of acute liver damage, further examination of this
issue will be necessary.
Recently, the prevalence of non-alcoholic fatty liver
disease (NAFLD) has been increasing in Japan. Non-
alcoholic steatohepatitis (NASH), one of the conditions of
NAFLD, was first reported by Ludwig et al. [ 14]. It is
considered that fatty liver progresses further to NASH
under conditions such as oxidative stress and the action of
inflammatory cytokines. The histopathological picture in
patients with NASH resembles that of alcoholic steato-
hepatitis. However, this condition is harder to treat than
alcoholic steatohepatitis, and can lead to liver cirrhosis or
cancer. It has been reported that α-Toc is effective for
NASH, and it has already been applied therapeutically. A
report by Hasegawa et al. [15] indicated that ALT activity in
the serum of NASH patients was reduced, and that the
histopathological picture (fatty degeneration, inflammation,
and fibrosis) was improved by administration of α-Toc
(300 mg/day) for one year. Similar therapeutic application
of γ-Toc and T3s is expected.
In summary, administration of vitamin E analogs has been
shown to improve the liver damage induced by CCl4 in rats,
and it is suggested that the improvement effect of T3s is
stronger than that of γ-Toc. From reports that T3s are
effective for treatment of NASH, similar effects are expected
for these other vitamin E analogs. A further experiment is
necessary for comparison of the effect of each T3 analog.
Moreover, detailed examinations employing other models
are planned.
Fig. 5. Contents of individual vitamin E analogs in liver and plasma of rats administered CCl4; (A) Liver α-Toc content. (B) Plasma
α-Toc content. (C) Liver γ-Toc content. (D) Plasma α-T3 content. Rats were fed a vitamin E-deficient diet for four weeks.
After a 24 h fast, 20 mg of each vitamin E analog was administered to the rats. Six hours later, a mixture of CCl4 and stripped
corn oil (1:1, 1 ml/kg body weight; 0.5 ml/kg body weight as CCl4) was administered orally to the rats. The control rats were
given stripped corn oil alone as a placebo. Six hours after CCl4 administration, the liver and plasma were taken, and the quantity
of each vitamin E analog was measured by HPLC. C; Control group, CCl4; CCl4 dosage group, αT;  α-Toc dosage group,
αT + CCl4; α-Toc + CCl4 dosage group, γT; γ-Toc dosage group, γT + CCl4; γ-Toc + CCl4 dosage group, T3; T3 mix dosage
group, T3 + CCl4; T3 mix + CCl4 dosage group. The values are mean ± SD for 5 rats, *p<0.05 (one-way ANOVA followed by
Bonferroni post hoc test).R. Yachi et al.
J. Clin. Biochem. Nutr.
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